A testing dose was unnecessary, Novartis believed, given that valsartan 320mg (160mg twice a day) had been tested in heart failure and with a 1:1 ratio with sacubitril. "I had nothing to learn ...

MSN Pharma was given FDA approval for its Entresto (sacubitril and valsartan) generic on 24th July, prompting a lawsuit from Novartis claiming patent infringement and seeking a preliminary ...

After Novartis and Roche grew their sales last year, the Swiss pharma giants are handing their CEOs larger compensation packages for 2024. At Novartis, CEO Vas Narasimhan’s overall 2024 pay ...

Novartis (NVS) CEO Vas Narasimhan told the Wall Street Journal the company is searching for next-generation obesity drug candidates, even if its main focus remains on therapeutic areas where it ...

February 26, 2025 Sandoz family to get $2.9 billion from offloading part of its Novartis stake The investment vehicle of the Sandoz family will get 2.6 billion Swiss francs ($2.90 billion ...

Novartis has set a high bar for any potential obesity-treatment acquisition as it scans the market for deals to fill its drug pipeline and power sales growth into the 2030s, its chief executive ...

The FDA has given Lupin approval for generic Entresto, and tentative approval for generic Triumeq. Kroger is cutting about 200 employees across three office sites, and Albertsons is laying off ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

L.L. has acted as a consultant for Merck, Novartis, and Bayer, and has received grants from Pfizer, Bayer, Merck, and Novartis. D.C.B. has served on the steering committee as a consultant for Merck.

We evaluated the novel use of valsartan to attenuate the occurrence of and progression of pulmonary vein stenosis following total anomalous pulmonary venous connection surgery. Subclinical pulmonary ...